Categories: EHRNews

WITTENSTEIN high integrity systems Have Released a New SAFERTOS® Demo for the Renesas RH850U2A16 Starter Kit

BRISTOL, United Kingdom, Nov. 3, 2025 /PRNewswire/ — WITTENSTEIN high integrity systems (WHIS) have released a new SAFERTOS® demo for the Renesas RH850U2A16 Starter Kit, providing engineers with hands-on access to a pre-certified safety RTOS on automotive-grade hardware.

The Renesas RH850U2A16 Starter Kit, paired with SAFERTOS®, opens the door to hands-on exploration of safety-critical embedded applications. Engineers can prototype on the full kit, everything from advanced sensor interfacing and digital power management to high-performance motor control, all on automotive-grade hardware designed for reliability under pressure. With SAFERTOS®‘ pre-certified safety features, developers can validate real-time performance, ensure system dependability, and test complex solutions before committing to production, turning a simple starter kit into a launchpad for certifiable, next-generation automotive systems.

The starter kit is based on the Renesas RH850/U2A cross-domain microcontroller, which consolidates multiple applications into a single chip to support unified ECUs for modern E/E architectures.

Developers can download the demos for free and begin testing SAFERTOS® on the RH850U2A16 Starter Kit today: https://www.highintegritysystems.com/down-loads/manuals-datasheets/safertos-datasheet-downloads/

“WITTENSTEIN has been a trusted toolchain partner across automotive and industrial for RH850, R-Car, RX, RZ, architectures for many years,” said Sandra Stehr, Senior Manager at Renesas Electronics. “With this SAFERTOS® release, RH850/U2A users can explore and develop safety-critical applications and a well-established development workflow.”

SAFERTOS® is a pre-certified safety RTOS for embedded systems developed by WHIS, a global safety systems company. It delivers superior performance and pre-certified dependability whilst utilizing minimal resources. SAFERTOS® is delivered with a Design Assurance Pack (DAP), tailored specifically for the customer processor/compiler combination. This enables SAFERTOS® to support a wide range of international development standards, including ISO 26262 ASIL D and IEC 61508 SIL 3 by TÜV SÜD, making it a trusted solution across multiple industries.

“These SAFERTOS® demos give developers the opportunity to experience the full capabilities of a pre-certified safety RTOS directly on the Renesas RH850U2A16 Starter Kit,” said Andrew Longhurst, Managing Director of WITTENSTEIN high integrity systems. “Engineers can validate performance, explore complex safety-critical applications, and build confidence before committing to production.”

Download a demo for free at: https://www.highintegritysystems.com/down-loads/manuals-datasheets/safertos-datasheet-downloads/ 

About WITTENSTEIN high integrity systems

WITTENSTEIN high integrity systems is a safety systems company that produces and supplies Real Time Operating Systems and platform solutions to the Automotive, Medical and Industrial sectors worldwide. For more information, please visit:
https://www.highintegritysystems.com.

View original content:https://www.prnewswire.com/news-releases/wittenstein-high-integrity-systems-have-released-a-new-safertos-demo-for-the-renesas-rh850u2a16-starter-kit-302600962.html

SOURCE WITTENSTEIN high integrity systems

Staff

Recent Posts

TempraMed Launches New Product, VIVI Cap Smart, Expanding Its Portfolio to Include a Digital Health Offering

Integrated smart technology builds on TempraMed's proven VIVI platform, providing robust Temperature control with medication…

41 minutes ago

More Than a Meal Plan: The Clinical Impact of a Kidney Dietitian

NORTHAMPTON, MA / ACCESS Newswire / December 26, 2025 / Specialized nutrition experts are key…

3 hours ago

President Trump’s Executive Marijuana Action Exposes the Truth-How the DEA Delayed Medicine While Protecting Everything Else

"Despite clear congressional mandates and FDA authorization, the Drug Enforcement Administration failed to act within…

3 hours ago

From Follower to Force: China’s Biotech Sector Enters the Global Clinical Mainstream

WASHINGTON, Dec. 26, 2025 /PRNewswire/ -- Over the past decade, China has evolved from a biotechnology…

6 hours ago

Aptevo Therapeutics Announces 1-for-18 Reverse Stock Split

SEATTLE, WA / ACCESS Newswire / December 26, 2025 / Aptevo Therapeutics Inc. (NASDAQ:APVO), a…

9 hours ago

Celularity CEO Comments on Centers for Medicare & Medicaid Services’ Withdrawal of Skin Substitute Local Coverage Determinations

While Celularity’s Biovance® and Biovance 3L products remained eligible for Medicare coverage under the now-withdrawn…

9 hours ago